Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,21%
1 091,51
-2,30
-0,21%
—1 093,811 096,521 100,221 091,51——
SIXC
Communications
SIXC
Communications
SIXC
+0,22%
610,11
+1,34
+0,22%
—608,77608,77612,97608,77——
SIXE
Energy
SIXE
Energy
SIXE
-1,34%
1 237,98
-16,83
-1,34%
—1 254,811 253,011 253,871 226,33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,93%
1 744,71
-16,40
-0,93%
—1 761,111 764,271 766,881 744,71——
SIXM
Financials
SIXM
Financials
SIXM
-0,37%
640,18
-2,40
-0,37%
—642,58644,87648,48640,18——
SIXR
Staples
SIXR
Staples
SIXR
-0,18%
849,58
-1,55
-0,18%
—851,13855,66858,75845,56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,23%
217,48
-0,50
-0,23%
—217,98217,98218,65216,88——
SIXT
Technology
SIXT
Technology
SIXT
+1,52%
3 260,69
+48,86
+1,52%
—3 211,833 227,213 268,383 226,55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,69%
942,45
-6,53
-0,69%
—948,98948,58957,83941,97——
SIXV
Health care
SIXV
Health care
SIXV
-0,52%
1 466,80
-7,72
-0,52%
—1 474,521 479,031 481,041 466,80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,22%
2 397,50
+5,38
+0,22%
—2 392,122 396,952 421,222 382,32——
1177:HKG
Sino Biopharmaceutical Ltd
HK$5,42
-0,73%
(-0,040) 1D
30 Apr., 16:08:11 GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 1177...
Open
HK$5,42
High
HK$5,49
Low
HK$5,41
Mkt. cap
101,60 mjd
Avg. vol.
78,27 m
Volume
66,45 m
Dividend
1,85%
Quarterly dividend
HK$0,03
Ex dividend date
29 Aug. 2025
P/E ratio
36,36
52-wk high
HK$9,12
52-wk low
HK$3,74
EPS
HK$0,15
Shares outstanding
12,64 mjd
No. of employees
21 k
News stories
From sources across the web
Profile
Sino Biopharmaceutical Limited, shortly Sino Biopharm, is a pharmaceutical conglomerate in China. The Company was listed on the Hong Kong Stock Exchange in 2000 and included in 2013 as a constituent stock of MSCI Global Standard Indices – MSCI China Index, Hang Seng Index in 2018, Hang Seng China Enterprises Index in 2019, and Hang Seng Connect Biotech 50 Index and Hang Seng China 25 Index in 2020. The Group’s principal subsidiaries include: Chia Tai Tianqing Pharmaceutical Group Co. Ltd., Beijing Tide Pharmaceutical Co. Ltd., Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd., Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd., Jiangsu Chia Tai Qingjiang Pharmaceutical Co., Ltd. and invoX Pharma Limited. Its products including biopharmaceutical and chemical medicines are used in a host of therapeutic areas, such as tumors, liver diseases, respiratory system diseases and surgery/analgesia. Wikipedia
About Sino Biopharmaceutical Ltd
CEOLi Yi
Employees21,4 k
Founded2000
Headquarters-
SectorPharmaceutical industry
Websitesbpgroup.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Mrt. 2025
Jun. 2025
Sep. 2025
Des. 2025
Revenue
8,79 mjd
8,79 mjd
7,13 mjd
7,13 mjd
Cost of goods sold
1,54 mjd
1,54 mjd
1,31 mjd
1,31 mjd
Cost of revenue
1,54 mjd
1,54 mjd
1,31 mjd
1,31 mjd
Research and development expenses
-
-
2,93 mjd
2,93 mjd
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,77 mjd
3,77 mjd
2,80 mjd
2,80 mjd
Operating expense
5,54 mjd
5,54 mjd
4,38 mjd
4,38 mjd
Total operating expenses
7,08 mjd
7,08 mjd
5,69 mjd
5,69 mjd
Operating income
1,70 mjd
1,70 mjd
1,44 mjd
1,44 mjd
Other non operating income
40,54 m
40,54 m
97,99 m
97,99 m
EBT including unusual items
2,98 mjd
2,98 mjd
488,22 m
488,22 m
EBT excluding unusual items
2,72 mjd
2,72 mjd
1,55 mjd
1,55 mjd
Income tax expense
490,66 m
490,66 m
323,77 m
323,77 m
Effective tax rate
16,45%
16,45%
66,32%
66,32%
Other operating expenses
1,77 mjd
1,77 mjd
-1,35 mjd
-1,35 mjd
Net income
1,69 mjd
1,69 mjd
-522,62 m
-522,62 m
Net profit margin
19,28%
19,28%
-7,33%
-7,33%
Earnings per share
-
-
-
-
Interest and investment income
989,64 m
989,64 m
196,36 m
196,36 m
Interest expense
-61,60 m
-61,60 m
-77,56 m
-77,56 m
Net interest expenses
928,03 m
928,03 m
118,80 m
118,80 m
Depreciation and amortization charges
-
-
-
-
EBITDA
1,97 mjd
1,97 mjd
1,66 mjd
1,66 mjd
Gain or loss from assets sale
-
-
-5,58 m
-5,58 m
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer